These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9605747)

  • 1. Location of several putative genes possibly involved in human breast cancer progression.
    Driouch K; Briffod M; Bièche I; Champème MH; Lidereau R
    Cancer Res; 1998 May; 58(10):2081-6. PubMed ID: 9605747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
    Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
    Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
    Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
    Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
    Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
    Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
    Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
    Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
    Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.
    Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF
    Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
    Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A
    Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.